hydrobromic acid

(redirected from Hydrobromide)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

hydrobromic acid

(hī'drəbrō`mĭk): see bromidebromide,
any of a group of compounds that contain bromine and a more electropositive element or radical. Bromides are formed by the reaction of bromine or a bromide with another substance; they are widely distributed in nature.
..... Click the link for more information.
.

hydrobromic acid

[¦hī·drə′brō·mik ′as·əd]
(inorganic chemistry)
HBr A solution of hydrogen bromide in water, usually 40%; a clear, colorless liquid; used in medicine, analytical chemistry, and synthesis of organic compounds.
References in periodicals archive ?
Hyoscine hydrobromide is a muscle relaxant and in itself not harmful.
Scopolamine hydrobromide and scopolamine methyl bromide were intraperitoneally injected 30 min before the test.
The report includes galantamine hydrobromide description, covers its application areas and related patterns.
Patients were then randomized to receive intravenous infusion of either saline solution or scopolamine hydrobromide at 4.
About NUEDEXTA NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations.
In the first phase, 579 subjects with MDD received first-line treatment with citalopram hydrobromide for eight weeks, 20mg daily for the first four weeks and 40mg daily for the next four weeks.
Drugs and Drugs, Vitamin supplements, scopolamine hydrobromide, Alteplase
TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that a subsidiary, Biovail Laboratories International SRL (BLS), has entered into a supply agreement with sanofi aventis US for the marketing and distribution of Aplenzin[TM] (bupropion hydrobromide tablets) in the United States and Puerto Rico.
The complaint relates to statements alleged to have been made by the Company and by certain officers in respect of Aplenzin[TM] (bupropion hydrobromide tablets) during the product's U.
TORONTO -- Biovail Corporation (NYSE: BVF) (TSX: BVF) announced today that it has received Approval from the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for Aplenzin[TM] (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide developed by Biovail for the treatment of depression in adults.
In a Phase 2 trial in patients who did not respond adequately to first-line treatment with citalopram hydrobromide that Targacept completed in 2006, patients whose citalopram regimen was augmented with mecamylamine showed greater improvement on symptoms of depression and irritability than patients who received citalopram and a placebo.